Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016–2017

Haiti is striving for zero local malaria transmission by the year 2025. Chloroquine remains the first-line treatment, and sulfadoxine/pyrimethamine (SP) has been used for mass drug-administration pilot programs. In March 2016, nationwide molecular surveillance was initiated to assess molecular resis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Eric Rogier, Camelia Herman, Curtis S. Huber, Karen E.S. Hamre, Baby Pierre, Kimberly E. Mace, Jacquelin Présumé, Gina Mondélus, Ithamare Romilus, Tamara Elismé, Thomas P. Eisele, Thomas Druetz, Alexandre Existe, Jacques Boncy, Jean F. Lemoine, Venkatachalam Udhayakumar, Michelle A. Chang
Format: Artigo
Idioma:Inglês
Publicat: Centers for Disease Control and Prevention 2020-05-01
Col·lecció:Emerging Infectious Diseases
Matèries:
Plasmodium falciparum
Haiti
drug resistance
chloroquine
sulfadoxine
pyrimethamine
Accés en línia:https://wwwnc.cdc.gov/eid/article/26/5/19-0556_article
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars